Viewing Study NCT01026402


Ignite Creation Date: 2025-12-25 @ 3:41 AM
Ignite Modification Date: 2026-01-24 @ 8:05 AM
Study NCT ID: NCT01026402
Status: COMPLETED
Last Update Posted: 2016-02-11
First Post: 2009-12-03
Is Gene Therapy: True
Has Adverse Events: True

Brief Title: Study to Assess the Safety, Tolerability, Pharmacokinetics (PK) and Preliminary Efficacy of AZD2014
Sponsor: AstraZeneca
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Advanced Solid Malignancies View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Phase I View
None cancer View
None advanced solid malignancies View
None dose escalation View
None AZD2014 View
None mTor kinase inhibitor View
None safety View
None pharmacokinetics View